Non-CYP2D6 Variants Selected by a GWAS Improve the Prediction of Impaired Tamoxifen Metabolism in Patients with Breast Cancer

por Hennig, Ewa E., Piątkowska, Magdalena, Goryca, Krzysztof, Pośpiech, Ewelina, Paziewska, Agnieszka, Karczmarski, Jakub, Kluska, Anna, Brewczyńska, Elżbieta, Ostrowski, Jerzy
Publicado 2019

Limited predictive value of achieving beneficial plasma (Z)-endoxifen threshold level by CYP2D6 genotyping in tamoxifen-treated Polish women with breast cancer

por Hennig, Ewa E., Piatkowska, Magdalena, Karczmarski, Jakub, Goryca, Krzysztof, Brewczynska, Elzbieta, Jazwiec, Radoslaw, Kluska, Anna, Omiotek, Robert, Paziewska, Agnieszka, Dadlez, Michal, Ostrowski, Jerzy
Publicado 2015